175 related articles for article (PubMed ID: 24193096)
1. Silica-F127 nanohybrid-encapsulated manganese oxide nanoparticles for optimized T1 magnetic resonance relaxivity.
Wei Hsu BY; Wang M; Zhang Y; Vijayaragavan V; Wong SY; Yuang-Chi Chang A; Bhakoo KK; Li X; Wang J
Nanoscale; 2014 Jan; 6(1):293-9. PubMed ID: 24193096
[TBL] [Abstract][Full Text] [Related]
2. pH-Activatable MnO-Based Fluorescence and Magnetic Resonance Bimodal Nanoprobe for Cancer Imaging.
Hsu BY; Ng M; Tan A; Connell J; Roberts T; Lythgoe M; Zhang Y; Wong SY; Bhakoo K; Seifalian AM; Li X; Wang J
Adv Healthc Mater; 2016 Mar; 5(6):721-9. PubMed ID: 26895111
[TBL] [Abstract][Full Text] [Related]
3. Manganese-impregnated mesoporous silica nanoparticles for signal enhancement in MRI cell labelling studies.
Guillet-Nicolas R; Laprise-Pelletier M; Nair MM; Chevallier P; Lagueux J; Gossuin Y; Laurent S; Kleitz F; Fortin MA
Nanoscale; 2013 Dec; 5(23):11499-511. PubMed ID: 24178890
[TBL] [Abstract][Full Text] [Related]
4. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
Li J; Wu C; Hou P; Zhang M; Xu K
Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
[TBL] [Abstract][Full Text] [Related]
5. Structure-property relationships in manganese oxide--mesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery.
Chen Y; Chen H; Zhang S; Chen F; Sun S; He Q; Ma M; Wang X; Wu H; Zhang L; Zhang L; Shi J
Biomaterials; 2012 Mar; 33(7):2388-98. PubMed ID: 22177841
[TBL] [Abstract][Full Text] [Related]
6. MnO-labeled cells: positive contrast enhancement in MRI.
Létourneau M; Tremblay M; Faucher L; Rojas D; Chevallier P; Gossuin Y; Lagueux J; Fortin MA
J Phys Chem B; 2012 Nov; 116(44):13228-38. PubMed ID: 23030472
[TBL] [Abstract][Full Text] [Related]
7. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
[TBL] [Abstract][Full Text] [Related]
8. Water-soluble MnO nanocolloid for a molecular T1 MR imaging: a facile one-pot synthesis, in vivo T1 MR images, and account for relaxivities.
Baek MJ; Park JY; Xu W; Kattel K; Kim HG; Lee EJ; Patel AK; Lee JJ; Chang Y; Kim TJ; Bae JE; Chae KS; Lee GH
ACS Appl Mater Interfaces; 2010 Oct; 2(10):2949-55. PubMed ID: 20929249
[TBL] [Abstract][Full Text] [Related]
9. L-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles.
McDonagh BH; Singh G; Hak S; Bandyopadhyay S; Augestad IL; Peddis D; Sandvig I; Sandvig A; Glomm WR
Small; 2016 Jan; 12(3):301-6. PubMed ID: 26619158
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence and drug loading properties of ZnSe:Mn/ZnS-Paclitaxel/SiO
Zhao T; Liu X; Li Y; Zhang M; He J; Zhang X; Liu H; Wang X; Gu H
J Colloid Interface Sci; 2017 Mar; 490():436-443. PubMed ID: 27914343
[TBL] [Abstract][Full Text] [Related]
11. Aptamer-conjugated Mn3O4@SiO2 core-shell nanoprobes for targeted magnetic resonance imaging.
Hu H; Dai A; Sun J; Li X; Gao F; Wu L; Fang Y; Yang H; An L; Wu H; Yang S
Nanoscale; 2013 Nov; 5(21):10447-54. PubMed ID: 24057072
[TBL] [Abstract][Full Text] [Related]
12. Development of PEGylated KMnF3 nanoparticles as a T1-weighted contrast agent: chemical synthesis, in vivo brain MR imaging, and accounting for high relaxivity.
Liu ZJ; Song XX; Tang Q
Nanoscale; 2013 Jun; 5(11):5073-9. PubMed ID: 23640287
[TBL] [Abstract][Full Text] [Related]
13. Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles.
Na HB; Lee JH; An K; Park YI; Park M; Lee IS; Nam DH; Kim ST; Kim SH; Kim SW; Lim KH; Kim KS; Kim SO; Hyeon T
Angew Chem Int Ed Engl; 2007; 46(28):5397-401. PubMed ID: 17357103
[No Abstract] [Full Text] [Related]
14. Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis.
Poon C; Gallo J; Joo J; Chang T; Bañobre-López M; Chung EJ
J Nanobiotechnology; 2018 Nov; 16(1):92. PubMed ID: 30442135
[TBL] [Abstract][Full Text] [Related]
15. Effect of Mesoporous Nano Water Reservoir on MR Relaxivity.
Sharmiladevi P; Haribabu V; Girigoswami K; Sulaiman Farook A; Girigoswami A
Sci Rep; 2017 Sep; 7(1):11179. PubMed ID: 28894269
[TBL] [Abstract][Full Text] [Related]
16. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells.
Chen Y; Yin Q; Ji X; Zhang S; Chen H; Zheng Y; Sun Y; Qu H; Wang Z; Li Y; Wang X; Zhang K; Zhang L; Shi J
Biomaterials; 2012 Oct; 33(29):7126-37. PubMed ID: 22789722
[TBL] [Abstract][Full Text] [Related]
17. A Prussian Blue-Based Core-Shell Hollow-Structured Mesoporous Nanoparticle as a Smart Theranostic Agent with Ultrahigh pH-Responsive Longitudinal Relaxivity.
Cai X; Gao W; Ma M; Wu M; Zhang L; Zheng Y; Chen H; Shi J
Adv Mater; 2015 Nov; 27(41):6382-9. PubMed ID: 26393889
[TBL] [Abstract][Full Text] [Related]
18. Marriage Strategy of Structure and Composition Designs for Intensifying Ultrasound & MR & CT Trimodal Contrast Imaging.
Zhang K; Chen H; Li P; Bo X; Li X; Zeng Z; Xu H
ACS Appl Mater Interfaces; 2015 Aug; 7(33):18590-9. PubMed ID: 26245739
[TBL] [Abstract][Full Text] [Related]
19. Folic acid-conjugated MnO nanoparticles as a T1 contrast agent for magnetic resonance imaging of tiny brain gliomas.
Chen N; Shao C; Qu Y; Li S; Gu W; Zheng T; Ye L; Yu C
ACS Appl Mater Interfaces; 2014 Nov; 6(22):19850-7. PubMed ID: 25335117
[TBL] [Abstract][Full Text] [Related]
20. Improving the sensitivity of
Yang L; Wang L; Huang G; Zhang X; Chen L; Li A; Gao J; Zhou Z; Su L; Yang H; Song J
Theranostics; 2021; 11(14):6966-6982. PubMed ID: 34093865
[No Abstract] [Full Text] [Related]
[Next] [New Search]
